NOVARTIS Stock London S.E.
Stocks
0HKE
CH0012005267
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 07-08 | Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal | FW |
| 07-07 | US FDA approves Vera's kidney disease drug | RE |
| Market Cap | 282B 247B 228B 210B 399B 26,892B 406B 2,721B 1,067B 13,247B 1,059B 1,036B 45,588B | P/E 2026 * |
21.5x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 314B 275B 254B 234B 444B 29,947B 452B 3,030B 1,189B 14,751B 1,179B 1,153B 50,766B | EV / Sales 2026 * |
5.52x | EV / Sales 2027 * | 5.15x |
| Free-Float |
91.66% | Yield 2026 * |
2.86% | Yield 2027 * | 2.95% |
Last Transcript: NOVARTIS
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -2.09% | +50.33% | +162.29% | 1,085B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 624B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 442B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 332B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 277B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 217B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 167B | |
| -0.33% | -0.62% | -6.25% | -32.26% | 138B | |
| Average | -0.74% | -1.57% | +20.90% | +46.94% | 386.45B | |
| Weighted average by Cap. | -0.43% | -0.88% | +34.53% | +80.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.86B 49.82B 45.94B 42.45B 80.47B 5,423B 81.82B 549B 215B 2,671B 213B 209B 9,193B | 60.3B 52.83B 48.71B 45.01B 85.34B 5,751B 86.76B 582B 228B 2,833B 226B 221B 9,749B |
| Net income | 14.08B 12.33B 11.37B 10.51B 19.92B 1,343B 20.26B 136B 53.29B 661B 52.86B 51.71B 2,276B | 15.64B 13.71B 12.64B 11.68B 22.14B 1,492B 22.51B 151B 59.21B 735B 58.73B 57.45B 2,529B |
| Net Debt | 32.03B 28.06B 25.87B 23.91B 45.32B 3,054B 46.08B 309B 121B 1,504B 120B 118B 5,178B | 28.54B 25B 23.05B 21.3B 40.39B 2,722B 41.06B 275B 108B 1,341B 107B 105B 4,614B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
- 0HKE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
